Since 1980, the Bruker Daltonics Corporation has developed as part of the global Bruker organization. Roots were the German Bruker-Franzen Analytik GmbH and the Swiss Spectrospin AG. These companies developed mobile detectors, as well as mass spectrometers for physical chemistry.
From 1990 on, the Daltonics business received a new momentum: Technological innovation now allowed for the analysis of fragile biomolecules. This development opened up new markets, which has been the major driving force for growth and global expansion of Bruker Daltonics through the last decade. Since 2003, Bruker Biosciences is a publicly listed company (NasdaqNM:BRKR).